SEEMA AHMED: Open Payments
NPI 1386994630 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,270 in 52 payments from 14 companies in 2025. Trend: 2023 $1,448 · 2024 $1,331 · 2025 $1,270
Food & beverage: $1,270
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $278 |
| Stryker Corporation | 2 | $189 |
| Novo Nordisk Inc | 9 | $181 |
| AstraZeneca Pharmaceuticals LP | 5 | $164 |
| PFIZER INC. | 6 | $119 |
| GlaxoSmithKline, LLC. | 5 | $112 |
| Amgen Inc. | 5 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Abbott Laboratories | 1 | $21 |
Products named: QULIPTA, FLOWTRIEVER CATHETER, S, BREZTRI, TRELEGY ELLIPTA, NURTEC ODT, Wegovy, OTEZLA, UBRELVY.
Industry payments across VA — which companies pay providers there.
